GVNG Technology
Eric Edidin is an advisor at GVNG and a board member at Spartacus Acquisition Corporation. Eric was previously with ILiAD Biotechnologies, LLC, BH3 Management, and Capillary Biomedical.
At Capillary Biomedical, Eric served as a board observer from January 2020 to July 2022. During their time there, they helped the company develop technologies for diabetes management, including the patent-pending SteadiSet infusion set for insulin pump therapy.
Eric has been instrumental in helping various businesses grow and develop over the years. Eric's experience and expertise have made him a valuable asset to any team.
Eric Edidin graduated with a BBA from the University of Michigan in finance and accounting. Eric then went on to obtain their MBA from Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices